A Study to Learn About the First and Later Lines of Medicines in Treating People With Metastatic Renal Cell Carcinoma (mRCC).

Condition:   Metastatic Renal Cell Carcinoma Intervention:   Sponsor:   Pfizer Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials